OKTO Launches: New Approach for Pain Management Reports NDIBA®

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

February 1, 2021

OKTO, is a a radiofrequency equipment with a stable 448kHz current perfect for treating acute and chronic pain, based on high-frequency neuromodulation of pain and metabolic stimulation of biological tissues.

“This hands-free equipment is a revolutionaly approach for pain management. It improves musculoskeletal and joint pain such as neuropathies, discopathies, osteoarthritis, osteochondrosis and post-traumatic injuries,” says Remco Schmitz, INDIBA CEO.

“Additionally, it will help clinics to save time and resources during consultation while offering the INDIBA guarantee of results on pain management,” says Diederik van Goor, ACTIV business unit leader.

At the heart of INDIBA Solutions, this device is targeted to Chiropractors, Physiotherapists, Pain Medicine, Physical therapists, Sports medicine specialists, Sports injury specialists, osteopaths, and Physical Rehab doctors.

The mechanism of action combines its scientifically proven enhancement of stem cell proliferation with the stimulation of neurovascular zones. OKTO’s eight active channels will allow professionals to work superficially or with full depth depending on the anatomical needs of each situation or pathology acting over the spine ganglions or over the peripheral nerve system giving an anthineuralgic and antineurithic effect.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles